Tag: development

Posted on

Amgen Publishes Asthma Drug Proof-of-Concept in NEJM – Drug Discovery & Development


Drug Discovery & Development

Amgen Publishes Asthma Drug Proof-of-Concept in NEJM
Drug Discovery & Development
Amgen announced that The New England Journal of Medicine (NEJM) published positive results from a Phase 1 study adding to the growing body of evidence that inhibiting thymic stromal lymphopoietin (TSLP) could be beneficial in the treatment of asthma.
Novel Antibody Demonstrates Promise against AsthmaGenetic Engineering News
Amgen drug for allergy asthma shows promise in early testsSFGate
Novel Biologic Promising for Allergic AsthmaMedPage Today
News-Medical.net –Daily Digest
all 31 news articles »

View full post on asthma – Google News

Posted on

Target Promising in Asthma and Cancer – Drug Discovery & Development


Drug Discovery & Development

Target Promising in Asthma and Cancer
Drug Discovery & Development
Mice without the enzyme SKG1 were resistant to dust mite-induced asthma. In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target …
Novel Molecular Target for Asthma and Cancer IdentifiedGenetic Engineering News
`Immune system` regulating enzyme can help treat asthma and cancerDaily News & Analysis

all 13 news articles »

View full post on asthma – Google News

Posted on

Boehringer Ingelheim Presents Phase 3 Data for Tiotropium Across Asthma … – Drug Discovery & Development

Boehringer Ingelheim Presents Phase 3 Data for Tiotropium Across Asthma …
Drug Discovery & Development
Boehringer Ingelheim announced new data from large scale, Phase 3 studies showing that once-daily tiotropium delivered via the Respimat inhaler was effective and well tolerated in patients across asthma severities. These data were presented at the …
Tiotropium as Asthma Add-On Treatment Shows PromiseMonthly Prescribing Reference

all 7 news articles »

View full post on asthma – Google News

Posted on

Asthma Drug Aids Simultaneous Desensitization to Food Allergies – Drug Discovery & Development


Drug Discovery & Development

Asthma Drug Aids Simultaneous Desensitization to Food Allergies
Drug Discovery & Development
Patients who took the asthma drug omalizumab became desensitized to multiple food allergens, including nuts An asthma drug accelerates the process of desensitizing patients with food allergies to several foods at the same time, a new study by …
Asthma drug aids simultaneous desensitization to several food allergies, study …Science Codex
Asthma drug helps relieve food allergies, study findsConsumerAffairs
Asthma Drug Helped Desensitize Body to Food Allergies at a Faster RateCounsel & Heal
Medscape –MedPage Today
all 9 news articles »

View full post on asthma – Google News

Posted on

Interferon Research Offers New Hope for Asthma Drugs – Drug Discovery & Development


Drug Discovery & Development

Interferon Research Offers New Hope for Asthma Drugs
Drug Discovery & Development
Fear has cloned 14 subtypes of Interferon from RNA samples and hopes her work will not only contribute to the development of a drug that will target asthma, but also cancer- her other field of research. Fear is investigating links between viral …

and more »

View full post on asthma – Google News

Posted on

KaloBios to Stop KB003 Development for Asthma – Analyst Blog – NASDAQ

KaloBios to Stop KB003 Development for Asthma – Analyst Blog
NASDAQ
KaloBios Pharmaceuticals, Inc. ( KBIO ) announced disappointing top line results from a phase II study on KB003 in patients suffering from severe asthma, where the candidate failed to meet the key endpoints. We expect the news to have a significant …
KaloBios shares tank on failed asthma drug trialSan Francisco Business Times (blog)
KaloBios calls it quits on its asthma drug after a Phase II flopFierceBiotech
KaloBios Pharma pulls plug on asthma drug, shares plungeReuters
MarketWatch
all 32 news articles »

View full post on asthma – Google News

Posted on

KaloBios to Stop KB003 Development for Asthma – Zacks.com

KaloBios to Stop KB003 Development for Asthma
Zacks.com
KaloBios Pharmaceuticals, Inc. (KBIO – Snapshot Report) announced disappointing top line results from a phase II study on KB003 in patients suffering from severe asthma, where the candidate failed to meet the key endpoints. We expect the news to have a …
KaloBios calls it quits on its asthma drug after a Phase II flopFierceBiotech
KaloBios Pharma pulls plug on asthma drug, shares plungeReuters
KaloBios Shares Slide on Move to Stop Asthma Treatment StudyWall Street Journal
RTT News –San Francisco Business Times (blog)
all 30 news articles »

View full post on asthma – Google News

Posted on

Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer – Drug Discovery & Development


Drug Discovery & Development

Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer
Drug Discovery & Development
Cancer Research UK and Cancer Research Technology–the charity's development and commercialization arm–have reached an agreement with AstraZeneca to take AZD2098, an experimental drug originally designed for asthma, into a clinical trial to treat …
Cancer Research UK to Repurpose AstraZeneca Asthma Drug for Kidney CancerGenetic Engineering News

all 2 news articles »

View full post on asthma – Google News

Posted on

Early-Life Air Pollution Strongly Linked To Asthma Development In Minority … – Medical Daily

Early-Life Air Pollution Strongly Linked To Asthma Development In Minority …
Medical Daily
A new study looked at the causal relationship between air pollution and childhood asthma. Air pollution exposure prior to the development of asthma was noted in order for researchers to definitively determine a difference in a child's asthma condition.

View full post on asthma – Google News

Posted on

New Understanding of Asthma Development: Transmission of Respiratory … – Science Daily (press release)

New Understanding of Asthma Development: Transmission of Respiratory …
Science Daily (press release)
"Epidemiologic evidence suggests that early-life RSV infection predisposes children to recurrent wheezing and asthma," said Giovanni Piedimonte, M.D., the study's lead author and Chairman of Cleveland Clinic Children's Hospital and the Pediatric Institute.
Research and Markets: EpiCast Report: Pediatric Respiratory Syncytial Virus …Fort Mills Times

all 3 news articles »

View full post on asthma – Google News